NRAS and cancer: In these cancers, TBK1 activity is positively correlated with disease progression thus serving as an indicator of poor prognosis, specifically in those tumors harboring activated K-RAS/N-RAS, suggesting TBK1 functions as an oncoprotein at least in these cancer types [16, 79, 142, 165, 174, 224–226].